Company News

Welcome to BBCR’s next generation website! We invite you to come explore our new site, redesigned to provide a clear overview of how BBCR can help you with early clinical development, rare disease and orphan drug solutions.

April 18th, 2023 | Company News

We are pleased to share with you our newly enhanced website. Over the past several months, our team has carefully reviewed our processes, capabilities, and offerings in order to provide you with the clearest overview of how we help our clients. BBCR is dedicated to supporting pharmaceutical innovators in the specialized rare diseases and orphan […]

BBCR’s regulatory and clinical research consultants are experts in biologics, cell and gene therapies, and small molecule developments. Identifying areas of need or economic interest can help sponsors find homes for treatments for orphan indications.

February 10th, 2023 | Company News

Expert guidance is essential in an area where patients are few; a lack of previous studies may hamper progress as you mount an orphan petition and negotiate a clinical plan with the FDA. BBCR consultants have the experience to guide you through the Orphan clinical research process with a clinical plan and regulatory strategy for […]

Clients entrust BBCR to provide expert guidance in simplifying clinical plans and developing customized strategies and cost-effective clinical trials that nurture product strengths.

February 10th, 2023 | Company News

Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. Click the button below to learn more about how we have helped companies with their clinical trial needs.